Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
EVE Health Group Limited ( (AU:EVE) ) has shared an announcement.
EVE Health Group has announced a live investor webinar to update shareholders and investors on its strategy following the acquisition of Nextract Pty Ltd. The webinar will feature Mr. Damian Wood, the incoming CEO, who will discuss the company’s development pipeline and focus areas post-acquisition, as well as upcoming commercial and regulatory milestones. This event signifies EVE’s proactive approach to engaging with its stakeholders and highlights its strategic direction in the health industry.
More about EVE Health Group Limited
EVE Health Group (ASX: EVE) is an Australian-based company focused on developing and commercializing evidence-based wellness and pharmaceutical products. Through its subsidiaries, Meluka Australia and Nextract, EVE provides science-led innovations to support consumer and practitioner health across retail, pharmacy, and clinical channels.
Average Trading Volume: 1,013,601
Technical Sentiment Signal: Sell
Current Market Cap: A$5.27M
For detailed information about EVE stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue